Category - New Drugs
FDA Approves Apretude (cabotegravir extended-release injectable suspension) for HIV Pre-Exposure Prophylaxis (PrEP)
FDA Approves Yusimry (adalimumab-aqvh), a Biosimilar to Humira
FDA Approves Vyvgart (efgartigimod alfa-fcab) for the Treatment of Generalized Myasthenia Gravis
FDA Approves Tezspire (tezepelumab) for Severe Asthma
U.S. FDA Approves Supplemental New Drug Application for Expanded Indication of Oxbryta (voxelotor) for Children as Young as 4 Years of Age with Sickle Cell Disease
FDA Approves Dartisla ODT (glycopyrrolate) for Use in the Treatment of Peptic Ulcer
FDA Approves Tarpeyo (budesonide) to Reduce Proteinuria in IgA Nephropathy
U.S. Food and Drug Administration Approves Orencia (abatacept) in Combination with a Calcineurin Inhibitor and Methotrexate for the Prevention of Acute Graft Versus Host Disease (aGvHD)